Bupivacaine Hydrochloride Injection shortage
Bupivacaine Hydrochloride Injection is currently listed in shortage by the FDA. The FDA lists 62 affected products. The reported reason: Discontinuation of the manufacture of the drug; Demand increase for the drug; Other. This page was last refreshed from FDA data on Oct 1, 2026.
One specific strength of bupivacaine hydrochloride injection — 0.75% (15 mg/2 mL) mixed with 8.25% dextrose — currently has no available source. Most other strengths remain available from multiple manufacturers that have not reported a shortage.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Bupivacaine Hydrochloride Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Sep 22, 2026Currently in shortage62 of 62 products affected.
-
Sep 18, 2026FDA refreshed this shortage record1 product updated.
-
Sep 17, 2026FDA refreshed this shortage record8 products updated.
-
Sep 15, 2026FDA refreshed this shortage record10 products updated.
-
Sep 11, 2026FDA refreshed this shortage record6 products updated.
-
Jul 30, 2026FDA refreshed this shortage record1 product updated.
-
Jul 17, 2026FDA refreshed this shortage record6 products updated.
-
May 5, 2026FDA refreshed this shortage record10 products updated.
-
May 5, 2026More presentations reported5 more products added to the shortage.
-
Feb 20, 2018First reported to the FDA57 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Aspiro Pharma Limited 📞 732-529-0430, [email protected] 6 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-34) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-34) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-32) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-34) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-32) | — | Available | — | — |
Manufacturer: Eugia US LLC 📞 888-238-7880 8 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-170-30) | — | Available | Check wholesalers for inventory | — |
| Current | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-169-10) | — | Available | Check wholesalers for inventory | — |
| Current | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-172-30) | — | Available | Check wholesalers for inventory | — |
| Current | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50) | — | Available | Check wholesalers for inventory | — |
| Current | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-168-30) | — | Available | Check wholesalers for inventory | — |
| Current | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-167-10) | — | Available | Check wholesalers for inventory | — |
| Current | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50) | — | Available | Check wholesalers for inventory | — |
| Current | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-171-10) | — | Available | Check wholesalers for inventory | — |
Manufacturer: Fresenius Kabi USA, LLC 📞 888-386-1300 10 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17) | — | Available | Check wholesalers for inventory | — |
| Current | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31) | — | Unavailable | Estimated recovery: TBD | Delay in shipping of the drug |
| Current | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57) | — | Available | Check wholesalers for inventory | — |
| Current | Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17) | — | Available | Check wholesalers for inventory | — |
| Current | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31) | — | Unavailable | Estimated recovery: TBD | Demand increase for the drug |
| Current | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37) | — | Available | Check wholesalers for inventory | — |
| Current | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17) | — | Available | Check wholesalers for inventory | — |
| Current | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37) | — | Available | Check wholesalers for inventory | — |
| Current | Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37) | — | Available | Check wholesalers for inventory | — |
| Current | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57) | — | Available | Check wholesalers for inventory | — |
Manufacturer: Hospira, Inc., a Pfizer Company 📞 844-646-4398 20 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Marcaine, Injection, Marcaine 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01) | — | Limited Availability | Limited Supply Available. Next Delivery: May 2027; Estimated Recovery: June 2027 | Demand increase for the drug |
| Current | Marcaine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1530-01) | — | Available | — | — |
| Current | Marcaine, Injection, 225 mg/30 mL (NDC 0409-2253-25) | — | Available | Historical NDC: 0409-1582-29 | — |
| Current | Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01) | — | Available | — | — |
| Current | Marcaine, Injection, 250 mg/50 mL (NDC 0409-0525-25) | — | Available | Historical NDC: 0409-1610-50 | — |
| Current | Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-2253-01) | — | Available | Historical NDC: 0409-1582-29 | — |
| Current | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-01) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) | — | Available | — | — |
| Current | Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62) | — | Available | — | — |
| Current | Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10) | — | Unavailable | Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| Current | Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02) | — | Available | — | — |
| Current | Marcaine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-7535-01) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02) | — | Available | — | — |
| Current | Marcaine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-2510-01) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02) | — | Available | — | — |
| Current | Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1165-01) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01) | — | Available | — | — |
| Current | Marcaine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-5010-01) | — | Available | — | — |
Manufacturer: Huons Co., Ltd 📞 +82-2-854-4700 or via email [email protected] 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 73293-0002-2) | — | Unavailable | Estimated recovery: TBD | Demand increase for the drug |
Manufacturer: Kindos Pharmaceuticals Co. Ltd. 📞 844-824-8426 10 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32) | — | — | Discontinuation of the manufacture of the drug | — |
| Current | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32) | — | Limited Availability | Meitheal Pharmaceuticals is distributor/labeler | Discontinuation of the manufacture of the drug |
| Current | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32) | — | Limited Availability | Meitheal Pharmaceuticals is distributor/labeler | Discontinuation of the manufacture of the drug |
| To Be Discontinued | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32) | — | — | Discontinuation of the manufacture of the drug | — |
| Current | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52) | — | Limited Availability | Meitheal Pharmaceuticals is distributor/labeler | Discontinuation of the manufacture of the drug |
| To Be Discontinued | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52) | — | — | Discontinuation of the manufacture of the drug | — |
| Current | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52) | — | Limited Availability | Meitheal Pharmaceuticals is distributor/labeler | Discontinuation of the manufacture of the drug |
| Current | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32) | — | Limited Availability | Meitheal Pharmaceuticals is distributor/labeler | Discontinuation of the manufacture of the drug |
Manufacturer: ONESOURCE SPECIALTY PTE LTD 📞 888-217-8103 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Bupivacaine Hydrochloride PRESERVATIVE FREE, Injection, 2.5 mg/1 mL 5mg / 1mL (NDC 72266-263-10) | — | Available | Distributed by Fosun Pharma USA Inc. | — |
Manufacturer: Somerset Therapeutics, LLC 📞 732-554-1037 6 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-10) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-01) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-25) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-10) | — | Available | — | — |
| Current | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-25) | — | Available | — | — |
These rows are manufacturer reports to the FDA for Bupivacaine Hydrochloride Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Bupivacaine Hydrochloride Injection? options further down this page.
Why is Bupivacaine Hydrochloride Injection in shortage?
Bupivacaine hydrochloride injection is on the FDA shortage list for a few different reasons, depending on which manufacturer and product you're looking at. The biggest issue involves Kindos Pharmaceuticals (whose products are distributed by Meitheal Pharmaceuticals) — they are permanently stopping production of their 2.5 mg/mL, 5 mg/mL, and 7.5 mg/mL versions, and those are now only in limited supply with no confirmed recovery date. Fresenius Kabi's Sensorcaine 2.5 mg/mL (one specific package size) is also currently unavailable because more people need it than usual, and they haven't given a firm date for when it will be back. There's also a separate product — bupivacaine 0.75% with dextrose (7.5 mg/mL in dextrose 8.25%) — that has a factory production delay, with the next delivery expected around November 2026 and a full recovery estimated for December 2026.
It's worth knowing that several other manufacturers — including Hospira/Pfizer, Eugia, Somerset Therapeutics, and Aspiro Pharma — are reporting their versions as currently available, though some notes suggest checking with wholesalers for inventory. This shortage reflects a complicated mix of one company permanently stopping certain products, higher-than-normal demand, and a manufacturing hold-up affecting a specific formulation.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Bupivacaine Hydrochloride Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Bupivacaine Hydrochloride Injection?
Bupivacaine Hydrochloride Injection, a local anesthetic used during procedures, is currently on the FDA shortage list. Because this is a hospital and clinic injectable, your care team usually manages its supply, but I want you to understand what the data shows.
Most strengths still have an available source. These include the common concentrations such as 2.5 mg/mL, 5 mg/mL, and 7.5 mg/mL products, along with Marcaine and Sensorcaine presentations. The one strength with no available source right now is the 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25%, with the manufacturer reporting an estimated recovery around December 2026.
The reported reasons include some manufacturers discontinuing certain products, higher demand, and shipping delays. The reassuring part is that 7 of 8 manufacturers are still reporting available supply, so most forms remain obtainable even though this shortage has lasted over a year.
- Do not stop, skip, or change your care plan on your own.
- If your strength still has supply, your pharmacy or clinic can order it by checking wholesalers and other manufacturers.
- The same medicine is made by other companies (such as Hikma, B. Braun, Camber, and Hospira); your pharmacy may be able to source one of these, though it may not be in local stock.
- If your exact strength is discontinued or cannot be found, ask your prescriber or pharmacist about options, such as a clinician-chosen alternative.
- Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle these calls.
This is general, national information and may not match your local stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Bupivacaine Hydrochloride Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Bupivacaine Hydrochloride Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL | Injection, Solution · Infiltration, Perineural | Hikma Pharmaceuticals USA Inc. | 00143-9328-10 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE 5 mg/mL | Injection, Solution · Perineural | Hikma Pharmaceuticals USA Inc. | 00143-9329-10 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL | Injection, Solution · Epidural, Retrobulbar | Hikma Pharmaceuticals USA Inc. | 00143-9332-10 |
| Bupivacaine Hydrochloride With Dextrose | BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL | Injection · Subarachnoid | B. Braun Medical Inc. | 00264-9379-88 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL | Injection, Solution · Epidural, Infiltration, Intracaudal, Perineural | Hospira, Inc. | 00409-1159-10 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE 5 mg/mL | Injection, Solution · Epidural, Intracaudal, Perineural | Hospira, Inc. | 00409-1162-10 |
| Marcaine | BUPIVACAINE HYDROCHLORIDE 150 mg/30mL | Injection, Solution · Epidural, Intracaudal, Perineural | Hospira, Inc. | 00409-1530-25 |
| Marcaine | BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL | Injection, Solution · Epidural, Retrobulbar | Hospira, Inc. | 00409-1582-10 |
| Marcaine | BUPIVACAINE HYDROCHLORIDE 25 mg/10mL | Injection, Solution · Epidural, Infiltration, Intracaudal, Perineural | Hospira, Inc. | 00409-2510-25 |
| Marcaine | BUPIVACAINE HYDROCHLORIDE 50 mg/10mL | Injection, Solution · Epidural, Intracaudal, Perineural | Hospira, Inc. | 00409-5010-25 |
| Marcaine | BUPIVACAINE HYDROCHLORIDE 75 mg/30mL | Injection, Solution · Epidural, Infiltration, Intracaudal, Perineural | Hospira, Inc. | 00409-7535-25 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL | Injection, Solution · Epidural, Infiltration, Intracaudal, Perineural | Camber Pharmaceuticals, Inc. | 31722-0275-31 |
Alternative dosage forms of Bupivacaine Hydrochloride
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 30 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Sensorcaine Mpf 5 mg/mL | Fresenius | 25 vials | — | AP | FDA listed |
| Bupivacaine HCl 5 mg/mL | Xellia | 10 vials | — | AP | FDA listed |
| Bupivacaine HCl 5 mg/mL | Xellia | 30 ml | — | AP | FDA listed |
| Bupivacaine Hydrochloride 5 mg/mL | Asclemed | 10 ml | — | AP | FDA listed |
| Bupivacaine Hydrochloride 5 mg/mL | Asclemed | 10 ml | — | AP | FDA listed |
| Bupivacaine Hydrochloride 5 mg/mL | NorthStar | 25 vials | — | AP | FDA listed |
| Bupivacaine Hydrochloride 5 mg/mL | ProPharma | 30 ml | — | AP | FDA listed |
| Bupivacaine Hydrochloride 5 mg/mL | Camber | 25 vials | — | AP | FDA listed |
| Bupivacaine Hydrochloride 5 mg/mL | Hikma | 10 vials | — | AP | FDA listed |
| Bupivacaine Hydrochloride 5 mg/mL | Sportpharm | 10 ml | — | AP | FDA listed |
| Bupivacaine Hydrochloride 5 mg/mL | Hikma | 10 vials | — | AP | FDA listed |
| Bupivacaine Hydrochloride 5 mg/mL | NorthStar | 10 vials | — | AP | FDA listed |
| bupivacaine hydrochloride 5 mg/mL | Meitheal | 1 vial | — | — | Discontinued |
| Bupivacaine Hydrochloride 5 mg/mL | Hospira, | 25 vials | — | AP | Discontinued |
| Sensorcaine MPF 5 mg/mL | Henry | 1 vial | — | AP | FDA listed |
| Marcaine 5 mg/mL | Henry | 1 vial | — | AP | FDA listed |
| Sensorcaine Mpf 2.5 mg/mL | Fresenius | 25 vials | — | AP | FDA listed |
| Bupivacaine Hydrochloride 2.5 mg/mL | NorthStar | 25 vials | — | AP | FDA listed |
| Bupivacaine Hydrochloride 2.5 mg/mL | Hikma | 10 vials | — | AP | FDA listed |
| Bupivacaine Hydrochloride 2.5 mg/mL | ProPharma | 30 ml | — | AP | FDA listed |
| Bupivacaine Hydrochloride 2.5 mg/mL | Camber | 25 vials | — | AP | FDA listed |
| Bupivacaine Hydrochloride 2.5 mg/mL | Cardinal | 5 vials | — | AP | FDA listed |
| bupivacaine hydrochloride 2.5 mg/mL | Meitheal | 1 vial | — | — | Discontinued |
| Bupivacaine Hydrochloride 2.5 mg/mL | Anthea | 10 vials | — | AP | FDA listed |
| Bupivacaine Hydrochloride 2.5 mg/mL | Sportpharm | 25 vials | — | AP | FDA listed |
| Bupivacaine Hydrochloride 2.5 mg/mL | Hospira, | 25 vials | — | AP | FDA listed |
| Marvona-25 SUIK 2.5 mg/mL | Asclemed | 1 vial | — | — | FDA listed |
| Bupivacaine Hydrochloride 2.5 mg/mL | Hikma | 10 vials | — | AP | FDA listed |
| Marcaine 2.5 mg/mL | Henry | 1 vial | — | AP | FDA listed |
| Bupivacaine Hydrochloride 2.5 mg/mL | NorthStar | 10 vials | — | AP | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Bupivacaine Hydrochloride Injection — that fall in the same broad treatment class (local anesthetics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other anesthesia shortages
Bupivacaine Hydrochloride Injection shortage FAQs
Is Bupivacaine Hydrochloride Injection in shortage?
Why is Bupivacaine Hydrochloride Injection in shortage?
Which products are affected?
When will Bupivacaine Hydrochloride Injection be available again?
Can I still get Bupivacaine Hydrochloride somewhere?
What should I do if I take Bupivacaine Hydrochloride Injection?
Still have a question about the Bupivacaine Hydrochloride Injection shortage?
Ask a pharmacist about this shortage →View Bupivacaine Hydrochloride Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.